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OBJECTIVES This study aimed to determine whether the myocardial T2 relaxation time, determined using
a black-blood magnetic resonance imaging (MRI) sequence, could predict acute heart
transplant rejection.
BACKGROUND The use of black-blood MRI sequences allows suppression of the confusing influence of blood
signal when myocardial T2 is calculated to detect myocardial edema.
METHODS A total of 123 investigations, including cardiac MRI and myocardial biopsy, were performed
8 6 11 months after heart transplantation. Myocardial T2 was determined using an original
inversion-recovery/spin-echo sequence.
RESULTS A higher than normal T2 ($56 ms) allowed an accurate detection of the moderate acute
rejections evidenced at baseline biopsy ($International Society for Heart and Lung
Transplantation grade 2): sensitivity, 89% and specificity, 70% (p , 0.0001). T2 was increased
in grade 2 (n 5 11) compared with grade 0 (n 5 49, p , 0.05), grade 1A (n 5 34, p , 0.05)
and grade 1B (n 5 21, p , 0.05); T2 was further increased in grade 3 (n 5 8) compared with
grade 2 (p , 0.05). In addition, in patients without rejection equal to or greater than grade
2 at baseline, a T2 higher than normal ($56 ms) was correlated with the subsequent
occurrence of equal or greater than grade 2 rejection within the next three months: sensitivity
63% (12/19) and specificity 78% (64/82) (p 5 0.001).
CONCLUSIONS Myocardial T2, determined using a black-blood MRI sequence, is sufficiently sensitive to
identify most of the moderate acute rejections documented with biopsy at the same time, but
is also a predictor of the subsequent occurrence of such biopsy-defined rejections. (J Am Coll
Cardiol 2001;37:825–31) © 2001 by the American College of Cardiology
Survival after cardiac transplantation has improved thanks
to the use of more specific immunosuppressive drugs and
the extensive use of endomyocardial biopsies, which allow
acute rejection to be detected before allograft dysfunction
(1). However, endomyocardial biopsy leads to nonnegligible
patient risk and discomfort (2) and has some limitations,
such as the possibility of false negative results (3) and
variability of interpretation (4). Therefore, looking for
alternative noninvasive techniques is clinically warranted.
The measurement of the magnetic resonance [H1] re-
laxation times allows a noninvasive detection of myocardial
edema and has been shown to detect acute allograft rejection
in animals (5–10). Preliminary reports using conventional
magnetic resonance imaging (MRI) sequences in humans
have, however, given discrepant results (11–14). We previ-
ously reported that [H1] myocardial relaxation times in
healthy subjects could be precisely determined by combined
spin-echo and inversion-recovery sequences on a moderate
field strength (0.5 T) magnet (15,16). Moreover, in a
preliminary report, we observed that a single spin-echo/
inversion-recovery (“black-blood”) sequence, allowing a
rapid and precise determination of the myocardial transver-
sal relaxation time (T2), was able to detect episodes of acute
heart transplant rejection in humans (17). The aim of this
current study was to determine the usefulness of this MRI
procedure in the detection and prediction of biopsy-defined
acute heart transplant rejection.
METHODS
Study population. At our institution during a four-year
period, we had the opportunity to perform two MRI
examinations weekly in patients with heart transplant. The
patients were referred to MRI on the basis that: 1) they were
hospitalized either for a suspected rejection or for scheduled
systematic investigations; 2) they had no evidence of either
myocarditis or myocardial infarction; 3) they had no con-
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traindication for MRI; and 4) they gave informed consent to
undergo this additional investigation. When more than two
patients could be selected, only the two believed to have the
higher probability of acute rejection were referred to MRI:
those having signs suggestive of rejection at clinical exam-
inations (fever, fatigue) or at Doppler-echocardiography
(left ventricle [LV] systolic dysfunction, abnormal diastolic
pattern) or, in the absence of any sign of rejection, those
who had the shorter delay time from transplantation.
For the present study, which was undertaken to analyze
the relationship between the results from MRI and those
from myocardial biopsy, MRI investigations were retrospec-
tively selected according to the following criteria: 1) a
myocardial biopsy was obtained within one week of MRI; 2)
no intravenous treatment for acute rejection had been given
in the week preceding MRI or in the period between MRI
and myocardial biopsy; and 3) the patients were not iden-
tified as having a chronic transplant rejection at the time of
these investigations.
According to these criteria, 131 MRI procedures were
selected, among which eight were excluded because of poor
image quality (6%). Finally, 123 MRI procedures performed
in 68 patients were considered for this study. Thirty-five
patients had a single procedure and 33 had from two to four
procedures.
Twenty MRIs were performed in women (16%) and
mean age of the patients was 50 6 13 years (from 16 to 69
years) at the time of MRI. The mean time delay between
MRI and myocardial biopsy was 1 6 3 days. MRI was
performed in patients with suspected acute rejection (on the
basis of clinical or echographic data) in 49 cases (40%) and
as a systematic control in 74 (60%). Mean delay between
heart transplantation and MRI was 8 6 11 months (from
one week to six years) and MRI was performed within the
year following transplantation in 101 cases (82%).
Magnetic resonance imaging. Magnetic resonance imag-
ing was carried out on a whole-body magnet operating at a
field strength of 0.5 T (MRmax, General Electric, Milwau-
kee, Wisconsin). As previously described (15–17), the
imaging protocol started with multislice pilot scans oriented
in the coronal plane, and thereafter along the long axis of
the left ventricle.
A single slice, which allowed a clear view of the intra-
ventricular septum and which was the most central among
the left ventricular oblique views, was chosen for the T2
determination sequence.
The black-blood sequence was constituted by a 180°
inversion nonselective pulse followed by a conventional
spin-echo selective pulse sequence. An inversion time of
800 ms was chosen to withdraw most of the blood-related
signal. This time value was determined by the equation: t 5
ln(2) 3 T1, where T1 represents the longitudinal relaxation
time of blood at 37° C and at a field strength of 0.5 T (18).
Six echoes were acquired with echo times (TE) of 15, 30,
45, 60, 75 and 90 ms. Imaging was performed with a field
of view of 42 cm, a scanning matrix of 224 3 64 and a “no
phase wrap” function. In order to increase the amount of
myocardial signal (which was decreased by the use of the
inversion pulse), a slice thickness of 20 mm was used, image
acquisition was gated to the systolic period at the falling
edge of the T wave (to image a broader myocardial thick-
ness) and as many as four excitations were recorded. The
repetition time was forced to fall in the range 2,000 to
3,000 ms. An example of the images provided by the
black-blood sequence is given in Figure 1.
Two to three circular regions of interest, including the
external borders of the myocardium, were placed along the
intraventricular septum on the first echo image and repro-
duced unchanged on other echo images. To avoid the
confusing influence of signal from surrounding fat, the other
left ventricular walls (apical and lateral) were not analyzed.
The T2 calculation was performed with a standard lin-
earized least-square fit applied on the myocardial signal
measured on the echo images and based upon the equation
M(TE) 5 M0e
2TE/T2, TE being the echo time and M(TE)
the averaged signal from all regions of interest of the
corresponding TE image. Examples of linear fits are given
in Figure 2.
For the 47 initial patients, an additional determination of
Abbreviations and Acronyms
IVRT 5 isovolumetric relaxation time
LV 5 left ventricle
MRI 5 magnetic resonance imaging
PHT 5 pressure half-time
SD 5 standard deviation
T2 5 [H
1] transversal relaxation time
Figure 1. Example of images obtained using the black blood sequence with
echo images at 15, 30, 45, 60, 75 and 90 ms. The ratios, calculated for each
echo image between the myocardial signal from septal wall and the blood
signal from left ventricle cavity, were 9.7 at 15 ms, 5.8 at 30 ms, 3.9 at
45 ms, 3.4 at 60 ms, 2.6 at 75 ms and 2.1 at 90 ms.
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T2 was obtained with a standard spin-echo sequence applied
on the same slice, and thus without inversion pulse and with
more conventional parameters: slice thickness of 10 mm,
two excitations, scanning matrix of 224 3 128 and four
echoes acquired with echo times of 15, 30, 45 and 60 ms.
Finally, the reproducibility of T2 measurement has been
assessed in 23 cases where two consecutive black-blood
sequences have been performed.
Doppler studies. The results from transmitral Doppler
could be analyzed in 105 cases (85%) where a Doppler-
echocardiographic study was performed within 48 h of MRI
without prior intravenous treatment for acute rejection and
where at least one previous Doppler analysis could be used
as a normal reference.
Using a 3 MHz combined imaging and Doppler trans-
ducer (Vingmed CFM 750, Horten, Norway), pulsed-wave
transmitral Doppler tracings were recorded from the apical
four-chamber view by experienced physicians. The sample
volume was positioned at the level of the tips of mitral
leaflets and two diastolic parameters were determined (19):
1) the isovolumetric relaxation time (IVRT), calculated as
the time interval between aortic closure and the onset of
mitral flow, and 2) the pressure half-time of early mitral
flow deceleration (PHT).
An abnormal diastolic pattern, suggestive of acute rejec-
tion, was defined as a .15% decrease in either PHT or
IVRT when compared with normal reference values (19).
For each individual, the normal reference value was deter-
mined by averaging the last values (up to three) that had
been calculated in the absence of suspected rejection.
Transvenous endomyocardial biopsies. Transvenous en-
domyocardial biopsies were performed only as clinically
indicated for systematic control or in case of suspected
rejection. The systematic controls were performed at the
following rates: at two-week intervals for the first four
months following transplantation, then at monthly intervals
until the end of the first year, and finally at two-month
intervals during the second year. Using an extensively
described method (1), at least four specimens of right
ventricular tissue were obtained. Biopsies were interpreted
by experienced pathologists and graded according to
ISHLT (20): no evidence of rejection (grade 0); focal (grade
1A) or diffuse (grade 1B) mild signs of rejection; focal
(grade 2), multifocal (grade 3A) or diffuse (grade 3B)
moderate signs of rejection; and severe signs of rejection
(grade 4).
Statistical analysis. Comparisons between discrete vari-
ables and comparisons between proportions were made
using the Fisher exact test. Continuous variables were
expressed as mean 6 standard deviation and compared with
nonparametric tests: Mann-Whitney U and Wilcoxon tests
were used for unpaired and paired two-group comparisons,
respectively, and multiple unpaired comparisons were per-
formed using the Kruskal Wallis analysis of variance. For all
tests, a p value , 0.05 was considered to be indicative of a
significant difference.
RESULTS
Detection of acute graft rejection. On the biopsies per-
formed at baseline, there were 49 ISHLT grade 0 (40%), 34
grade 1A (28%), 21 grade 1B (17%) and 19 (15%) $grade
2 rejections: 11 grade 2, seven grade 3A and one grade 3B.
As illustrated in Figure 3, the averaged T2 values were
similar between grade 0 (50 6 5 ms), grade 1A (51 6 5 ms)
and grade 1B (51 6 8 ms). In contrast, T2 was significantly
higher in grade 2 (57 6 5 ms) than in either grade 0, grade
Figure 2. Examples of linear fits allowing the myocardial T2 determination and obtained in the same patient (1) (black squares) at the time of a grade 3
rejection at biopsy and (2) (white squares) one week later, after the intravenous treatment of acute rejection. The fit is applied on the linear decrease with
time of the logarithm of myocardial signal intensity. T2 is calculated as the inverse of the slope. T2 5 [H
1] transversal relaxation time.
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1A or grade 1B (all p , 0.05); and T2 was even higher in
grade 3 (65 6 8 ms) than in grade 2 rejection (p , 0.05).
T2 was markedly higher in patients with than in those
without moderate ($grade 2) rejection at biopsy (60 6 7 ms
vs. 51 6 6 ms, p 5 0.0001) and a T2 $2 SD of normal
($56 ms [15]) was the best cutoff value to separate patients
with and without $grade 2 rejection: sensitivity was 89%
(17/19) and specificity 70% (73/104). This criterion was
associated with a high negative predictive value (97%) but
with a much lower positive predictive value (35%) in the
detection of $grade 2 rejection.
As detailed in Table 1, no other analyzed variable was
significantly related to the presence of $grade 2 rejection at
biopsy, except for the IVRT, determined with transmitral
Doppler, which was lower and showed a higher decrease in
$grade 2 rejection compared with previous analyses.
Among the 47 initial patients for whom T2 had addi-
tionally been determined using a conventional spin-echo
sequence, eight had a $grade 2 rejection. Compared with
the T2 values provided by the black blood sequence, those
provided by the conventional sequence were higher and
showed a higher inter-individual variability which could be
documented both in the 8 patients who had a $grade 2
rejection (66 6 13 ms vs. 61 6 6 ms, p 5 0.04) and in the
39 others (53 6 12 ms vs. 49 6 6 ms, p 5 0.01). When T2
was compared between patients with and those without
$grade 2 rejection, the difference was more pronounced
with the black-blood sequence (61 6 6 ms vs. 49 6 6 ms,
p , 0.0001) than with the conventional sequence (66 6
13 ms vs. 53 6 12 ms, p 5 0.01), though the relationship
was statistically significant for both sequences.
Finally, in the 23 cases where two consecutive black-
blood sequences had been performed, the averaged differ-
ence in T2 value between the two measurements was found
to be 1.5 6 1.7 ms.
Follow-up analysis. In order to determine whether the
number of false positive results in the detection of moderate
rejections (T2 $56 ms but no $grade 2 rejection) might
correspond to an early stage of such biopsy-defined rejec-
tions, the subsequent occurrence of $grade 2 rejection over
the following three months was sought in the patients who
had no $grade 2 rejection at baseline.
During this period, three patients died without docu-
mented acute rejection and were excluded from the analysis:
two with normal T2 (,56 ms) died of a pulmonary cancer
and of a pulmonary infection, respectively, and one with an
abnormal T2 ($56 ms) had an unexplained sudden death.
Among the 101 cases that were finally considered for the
follow-up analysis, 19 had a $grade 2 rejection that was
documented during the three-month period by an addi-
tional biopsy (12 grade 2 and seven grade 3 rejections).
This additional biopsy was performed 15 to 92 days after
MRI (mean 50 6 27 days) as systematic control in 10 cases
(53%) and because of suspected acute rejection (on the basis
of clinical or Doppler data) in nine cases (47%).
In none of the remaining 82 cases was a $grade 2
rejection documented at biopsy during the three months of
Figure 3. Comparison of the averaged values of myocardial T2 (6 SD),
calculated in groups stratified according to the results of myocardial
biopsies performed at baseline (ISHLT grade 0, 1A, 1B, 2 and 3). p ,
0.05, for the adjusted comparisons among the five groups. T2 5 [H
1]
transversal relaxation time.
Table 1. Comparison of Data From Clinical History, MRI
and Transmitral Doppler, Between Patients With and Those











Age (yrs) 46 6 17 51 6 12 NS
Female gender 3 (16%) 17 (16%) NS
Delay-time from
transplantation (months)
12 6 19 10 6 18 NS
Recent history of acute
rejection (#1 month)
3 (16%) 10 (10%) NS
Clinical signs of acute
rejection




27 6 30 26 6 25 NS
Myocardial T2 at MRI
Value (ms) 60 6 7 51 6 6 0.0001
$2 SD of normal
($56 ms)
17 (89%) 31 (30%) ,0.0001
$1 SD of normal
($53 ms)
18 (95%) 52 (50%) 0.0002
Transmitral Doppler (n 5 18) (n 5 87)
Pressure half time
Value (ms) 46 6 21 41 6 16 NS
Change (%) 3 6 28 –5 6 19 NS
Isovolumetric relaxation time
Value (ms) 86 6 12 93 6 13 0.03
Change (%) –9 6 12 –2 6 12 0.01
NS 5 nonsignificant; SD 5 standard deviation; T2 5 [H
1] transversal relaxation
time.
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follow-up. In 68 cases (83%), this absence of rejection could
be ascertained by a myocardial biopsy performed after the
end of the follow-up period (on average, 20 6 20 days later).
In the remaining 14 cases, no additional biopsy was per-
formed after the follow-up period (because this was not
considered to be clinically warranted), but the absence of
any $grade 2 rejection was strongly suggested by an
event-free outcome of at least six months from MRI.
Myocardial T2 was significantly higher in patients with
than in those without $grade 2 rejection during the
three-month follow-up period (54 6 4 ms vs. 50 6 6 ms,
p , 0.05). As detailed in Table 2, neither clinical nor
Doppler parameters were significant predictors, except the
time delay between MRI and transplantation, which was
shorter in patients with than in those without $grade 2
rejection at follow-up (3 6 3 months vs. 12 6 20 months,
p , 0.05).
A T2 $2 SD of normal ($56 ms [15]) was correlated
(p , 0.05) with the occurrence of a $grade 2 rejection
within the three following months: the specificity was 78%
(64/82) and the sensitivity 63% (12/19). However, the
sensitivity was clearly time-dependent because 80% (4/5) of
the acute rejection detected in the first month of follow-up
had an abnormal T2 at baseline, whereas this was the case
for 67% (4/6) and 50% (4/8) of the rejections detected
during the second and the third months, respectively.
Finally, the criterion of an abnormal T2 ($56 ms) was
strongly associated with the occurrence of a $grade 2
rejection either at baseline or in the following three months,
this criterion having a high negative predictive value (88%)
and a lower positive predictive value (62%).
Significance of an abnormal T2 value in the absence of
any >grade 2 rejection at baseline and follow-up. Base-
line data from patients who had no $grade 2 rejection both
at baseline and at follow-up were compared between those
with and without an abnormal T2 value at baseline (Table
3). The only significant variable was the IVRT, which was
lower and showed a greater change compared with previous
analyses when T2 was abnormal. When T2 was abnormal,
the IVRT was significantly decreased compared with nor-
mal individual reference values (29 6 15%, p , 0.05);
when T2 was normal, by contrast, the IVRT was not
significantly changed (21 6 10%, NS).
DISCUSSION
The noninvasive detection of acute heart transplant rejec-
tion remains a clinical challenge. The present study reports
the results provided in this setting by a rapid (,30 min)
MRI procedure allowing a precise determination of the
myocardial T2.
Detection of acute rejection. Although the T2 values were
not significantly modified by the presence of mild signs of
rejection at biopsy (grade 1), there was an increase of T2
starting at the level of focal moderate signs of rejection
(grade 2); this increase was even higher in cases of grade 3
rejection.
The detection of moderate forms (grades 2 and 3) is
Table 2. Comparison of the Baseline Data, in the Patients Without $Grade 2 Rejection at
Baseline, Between Those Who Had and Those Who Had No $Grade 2 Rejection Over the









Age (yrs) 53 6 11 50 6 12 NS
Female gender 1 (5%) 16 (20%) NS
Delay time from transplantation (months) 3 6 3 12 6 20 , 0.05
Recent history of acute rejection (#1 month) 0 (0%) 10 (12%) NS
Clinical signs of acute rejection 4 (21%) 25 (30%) NS
Daily dose of corticosteroids (mg of prednisone-equivalent) 30 6 17 26 6 27 NS
Myocardial biopsy
Grade 0 8 (42%) 39 (48%) NS
Grade 1A 7 (37%) 26 (32%) NS
Grade 1B 4 (21%) 17 (21%) NS
Myocardial T2 at MRI
Value (ms) 54 6 4 50 6 6 , 0.05
$2 SD of normal ($56 ms) 12 (63%) 18 (22%) , 0.05
$1 SD of normal ($53 ms) 16 (84%) 34 (41%) , 0.05
Transmitral Doppler (n 5 15) (n 5 69)
Pressure half time
Value (ms) 39 6 17 41 6 16 NS
Change (%) 27 6 15 25 6 20 NS
Isovolumetric relaxation time
Value (ms) 98 6 12 92 6 13 NS
Change (%) 2 6 12 23 6 12 NS
NS 5 nonsignificant; SD 5 standard deviation; T2 5 [H
1] transversal relaxation time.
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clinically relevant because an intravenous treatment is rec-
ommended in this setting (21). The criterion of a clearly
abnormal T2 ($2 SD) was sufficiently sensitive to detect
most cases with moderate rejection at biopsy (89%). In
clinical practice, this high sensitivity might be useful in
selecting for endomyocardial biopsy only those patients with
an abnormal T2 value.
In addition, we have observed that compared with the T2
values provided by a conventional spin-echo sequence, those
provided by the black-blood sequence were shorter, exhib-
ited fewer interindividual variations and were more strongly
correlated to the presence of a $grade 2 rejection. The
superiority of the black-blood sequence can be explained by
the suppression of the blood signal and its confounding
effect on myocardial T2 measurement. Under conventional
spin-echo sequence, by contrast, the myocardial signal may
include variable proportions of signal related to blood, such
as that arising from myocardial capillaries or from ventric-
ular cavities (diffusing signal or flow artifacts), and it is likely
that this inclusion may lead to various increases in the
calculated values of myocardial T2.
Prediction of acute rejection. In a second analysis, we
tried to determine whether the number of cases with an
abnormal T2, but without $grade 2 rejection at baseline
biopsy, might correspond to an early stage of $grade 2
rejection. In this analysis, a T2 higher than normal was
highly correlated with the subsequent occurrence of $grade
2 rejection, and though the sensitivity was only 63% for the
entire follow-up period, it must be considered that this
percentage was markedly time-dependent, reaching as much
as 80% for the first month following MRI.
By contrast, the presence of mild signs of rejection at
baseline biopsy, as well as the results from transmitral
Doppler, were unrelated to the subsequent occurrence of
$grade 2 rejection. The only other baseline parameter that
was a significant predictor was the time delay from trans-
plantation, a point easily explained because the higher rates
of acute rejection are known to occur within the first months
following transplantation (22). Nevertheless, this study
shows that MRI has the capability to predict the subsequent
occurrence of moderate acute rejection as defined by biopsy,
an exciting property that might be useful in patient man-
agement.
Significance of an abnormal T2 in the absence of any
>grade 2 rejection. In as many as 38% of cases with
abnormal T2, a moderate-to-severe rejection was not docu-
mented by biopsy at baseline or follow-up. To our mind,
however, this point does not constitute a strong limitation
to the use of MRI. This is first because myocardial biopsy is
far from a perfect standard in this setting (given its variabil-
ity of interpretation [4] and nonnegligible rate of false
negative results [3]), and therefore acute rejection may not
be excluded in all cases with abnormal T2 but no evidence of
rejection at biopsy. Second, our Doppler data strongly
support the hypothesis of the presence of a real myocardial
edema in patients having an abnormal T2 but no biopsy-
defined rejection. Indeed, these patients also had evidence of
a LV diastolic dysfunction on the basis of IVRT analysis.
The mechanism of this possible edema, as well as its
long-term clinical consequences, remains to be determined.
Limitations of the study. Because of an insufficient avail-
ability of the MRI apparatus, the myocardial T2 could not
be determined in all transplanted patients having a myocar-
dial biopsy. Therefore, MRI was performed preferentially in
patients who had a suspected rejection on the basis of results
from clinical and Doppler echographic examinations. This
constitutes a situation where the use of an alternative
noninvasive technique, able to replace myocardial biopsy,
should be particularly helpful. However, it is unlikely that
this way to select patients might have had any important
impact on our results.
In addition, transmitral Doppler was not systematically
performed as part of the clinical study. Therefore, contrary
to MRI that were analyzed by a single observer, Doppler
data were collected by several physicians during routine
examinations. It is possible that this point might explain the
relativelydisappointing resultsprovidedby transmitralDopp-
ler and especially by the PHT determination. However, our
Doppler results are in agreement with those from several
studies where IVRT, but not PHT, has been shown to
correlate with biopsy-defined rejection (19,23).
Another point was that we have used a 0.5 T imager,
Table 3. Comparison of the Baseline Data, in the Patients
Without $Grade 2 Rejection Both at Baseline and at Follow-up,
Between Those Who Had and Those Who Had No Abnormal









Age (yrs) 49 6 12 51 6 12 NS
Female gender 5 (28%) 11 (17%) NS
Delay-time from
transplantation (months)
14 6 18 11 6 20 NS
Recent history of acute
rejection (#1 month)
1 (6%) 9 (14%) NS
Clinical signs of acute
rejection




26 6 30 26 6 27 NS
Myocardial biopsy
Grade 0 5 (28%) 34 (53%) NS
Grade 1A 9 (50%) 17 (27%) NS
Grade 1B 4 (22%) 13 (20%) NS
Transmitral Doppler (n 5 17) (n 5 52)
Pressure half time
Value (ms) 41 6 20 41 6 14 NS
Change (%) 212 6 28 24 6 17 NS
Isovolumetric relaxation time
Value (ms) 86 6 14 95 6 12 , 0.05
Change (%) 29 6 14 21 6 10 , 0.05
NS 5 nonsignificant; SD 5 standard deviation; T2 5 [H
1] transversal relaxation
time.
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whereas an enhanced image quality may be provided by
higher field imagers. Further studies will be required to
determine whether the use of high-field imagers may
enhance the results provided by black-blood MRI sequences
in this setting.
Finally, because this study included only patients having
a myocardial biopsy, and because biopsies are generally
performed early after transplantation, our patients were
investigated at short term from transplantation (eight
months on average). Therefore, the results of MRI remain
to be evaluated in older heart transplants.
Conclusion. In this population of patients with heart
transplant, the presence of an abnormal T2 value, as that
determined using a black-blood MRI sequence, could iden-
tify most of the moderate acute rejections documented with
biopsy performed at the same time, suggesting that routine
myocardial biopsy might be avoided in patients with normal
T2 value. An abnormal T2 value was also a strong predictor
of the subsequent occurrence of biopsy-defined acute rejec-
tions in the following months, original information that
might be helpful in patient management.
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